Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated May 23, 2023 (3 years ago)

Sodium Chloride 0.9% Injection

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of assurance of sterility: The product was potentially exposed to below-recommended storage temperatures, which may cause leaks in the packaging.

Cause type: Sterility / contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections. All sterility / contamination recalls.

What was recalled

Sodium Chloride 0.9% Injection, USP, 1000 mL bags, 12 bags per carton, Rx only, Fresenius Medical Care North America, Waltham, MA 02451, NDC # 49230-300-10

Affected NDC 49230-0300-10

Compare with the code on your package — it is the most precise check available.

Product details

From the FDA NDC directory, for the product code this recall names. Compare with the label on your package.

ProductStrengthForm & routeLabelerType
Sodium Chloride
NDC 49230-0300
900 mg/100mL Injection
Intravenous
Fresenius Medical Care Renal Therapies Group, LLC Rx
Recalling firm
Fresenius Medical Care Holdings, Inc.
NDC code
49230-300-10
Origin
MA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0777-2023 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other recalls by Fresenius Medical Care Holdings, Inc.

All 2023 recalls
Class II · Moderate risk

Delflex

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

Ongoing Sterility / contamination Fresenius Medical Care Holdings, Inc. D-0513-2026
Class II · Moderate risk

Delflex

Lack of Assurance of Sterility: Potential leaks from perforations in bags.

Ongoing Sterility / contamination Fresenius Medical Care Holdings, Inc. D-0512-2026

Other sterility / contamination recalls from 2023

All sterility / contamination recalls